FSDPX
Price
$91.56
Change
-$0.06 (-0.07%)
Updated
Aug 15 closing price
Net Assets
712.41M
IGNAX
Price
$17.10
Change
+$0.03 (+0.18%)
Updated
Aug 15 closing price
Net Assets
177.47M
Interact to see
Advertisement

FSDPX vs IGNAX

Header iconFSDPX vs IGNAX Comparison
Open Charts FSDPX vs IGNAXBanner chart's image
Fidelity Select Materials
Price$91.56
Change-$0.06 (-0.07%)
VolumeN/A
Net Assets712.41M
Macquarie Natural Resources A
Price$17.10
Change+$0.03 (+0.18%)
VolumeN/A
Net Assets177.47M
FSDPX vs IGNAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSDPX vs. IGNAX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSDPX is a Buy and IGNAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSDPX has more cash in the bank: 712M vs. IGNAX (177M). IGNAX pays higher dividends than FSDPX: IGNAX (5.14) vs FSDPX (0.93). FSDPX was incepted earlier than IGNAX: FSDPX (39 years) vs IGNAX (29 years). IGNAX (1.68) is less costly to investors than FSDPX (0.70). FSDPX is a more actively managed with annual turnover of: 65.00 vs. IGNAX (47.00). FSDPX has a lower initial minimum investment than IGNAX: FSDPX (0) vs IGNAX (1000). IGNAX annual gain was more profitable for investors over the last year : 11.51 vs. FSDPX (-3.53). IGNAX return over 5 years is better than : 79.02 vs. FSDPX (36.38).
FSDPXIGNAXFSDPX / IGNAX
Total Expense Ratio0.701.3651%
Annual Report Gross Expense Ratio0.701.6842%
Fund Existence39 years29 years-
Gain YTD8.94814.84260%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets712M177M402%
Annual Yield % from dividends0.935.1418%
Returns for 1 year-3.5311.51-31%
Returns for 3 years-5.5314.34-39%
Returns for 5 years36.3879.0246%
Returns for 10 years26.4132.1482%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX132.901.28
+0.97%
Neurocrine Biosciences
KIDS19.190.06
+0.31%
OrthoPediatrics Corp
SGA13.45-0.05
-0.37%
Saga Communications
APGE37.29-0.83
-2.18%
Apogee Therapeutics
ASNS0.51-0.11
-17.94%
Actelis Networks